Summary | With all the hype surrounding Renren's overpriced IPO
in New York, it's easy to lose sight of other offerings coming
out of China that look a bit more stable, especially in
fast-evolving areas like pharmaceuticals. With China trying
hard to create a sustainable healthcare system to replace an
older one that died with the end ...
youngchinabiz.com | 17 October 2015